Clinical manifestations of gastroesophageal reflux disease and anxiety in patients with metabolic syndrome

E. V. Shrayner; Шрайнер Е. В.; K. E. Kalashnikova; Калашникова К. Е.; V, I. Bystrova; Быстрова В. И.; D. A. Lukichev; Лукичев Д. А.; I. I. Smirnova; Смирнова И. И.; A. N. Sultanova; Султанова А. Н.; D. A. Kudlay; Кудлай Д. А.

doi:10.29296/25877305-2025-08-14

Clinical manifestations of gastroesophageal reflux disease and anxiety in patients with metabolic syndrome

Autores: Shrayner E.V.¹^,2, Kalashnikova K.E.¹, Bystrova V.I.¹^,2, Lukichev D.A.¹, Smirnova I.I.³, Sultanova A.N.³, Kudlay D.A.¹^,4^,5
Afiliações:
1. Novosibirsk State University
2. Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences
3. Novosibirsk State Medical University, Ministry of Health of Russia
4. I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
5. M.V. Lomonosov Moscow State University
Edição: Volume 36, Nº 8 (2025)
Páginas: 71-74
Seção: From Practice
URL: https://journals.rcsi.science/0236-3054/article/view/310725
DOI: https://doi.org/10.29296/25877305-2025-08-14
ID: 310725

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Texto integral
Sobre autores
Bibliografia
Arquivos suplementares
Estatísticas

Resumo

Metabolic syndrome (MS) is a global medical and social concern that significantly impacts various physiological systems, including the gastrointestinal tract. One of the most common associated pathologies is gastroesophageal reflux disease (GERD). This study aimed to evaluate the severity of clinical manifestations of GERD and anxiety disorders in patients with MS. A comparative analysis was conducted between two groups: patients with combined MS and GERD, and patients with isolated GERD. The study included clinical examination, assessment using the Spielberger State-Trait Anxiety Inventory (STAI), and instrumental diagnostics. The results demonstrated higher levels of anxiety and more severe GERD symptoms in patients with MS. A statistically significant association was revealed between MS and esophageal mucosal injury.

Palavras-chave

metabolic syndrome, gastroesophageal reflux disease, anxiety, obesity, esophagitis

Texto integral

##article.viewOnOriginalSite##

Sobre autores

E. Shrayner

Novosibirsk State University; Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences

Autor responsável pela correspondência
Email: sch704@icloud.com
ORCID ID: 0000-0003-3606-4068
Código SPIN: 1089-6080

Candidate of Medical Sciences

Rússia, Novosibirsk; Novosibirsk

Rússia, Novosibirsk

D. Kudlay

Novosibirsk State University; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); M.V. Lomonosov Moscow State University

Email: sch704@icloud.com
ORCID ID: 0000-0003-1878-4467
Código SPIN: 4129-7880

Professor, Corresponding Member of the Russian Academy of Sciences, MD

Rússia, Novosibirsk; Moscow; Moscow

Bibliografia

Vrdoljak J., Kumric M., Vilovic M. et al. Can Fasting Curb the Metabolic Syndrome Epidemic? Nutrients. 2022; 14: 456. doi: 10.3390/nu14030456
Hsieh Y.H., Wu M.F., Yang P.Y. et al. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study. BMC Gastroenterol. 2019; 19: 33. doi: 10.1186/s12876-019-0950-z
Городецкая И.В., Коневалова Н.Ю., Захаревич В.Г. Исследование ситуативной и личностной тревожности студентов. Вестник Витебского государственного медицинского университета. 2019; 18 (5): 120–7 [Gorodetskaya I.V., Konevalova N.Y., Zakharevich V.G. The study of the situational and personal anxiety of students. Vestnik VGMU. 2019; 18 (5): 120–7 (in Russ.)]. doi: 10.22263/2312-4156.2019.5.120
Zamani M., Alizadeh-Tabari S., Chan W.W. et al. Association Between Anxiety/Depression and Gastroesophageal Reflux: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2023; 118 (12): 2133–43. doi: 10.14309/ajg.0000000000002411
Choi J.M., Yang J.I., Kang S.J. et al. Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study. J Neurogastroenterol Motil. 2018; 24 (4): 593–602. doi: 10.5056/jnm18069
Ji S., Chen Y., Zhou Y. et al. Association between anxiety and metabolic syndrome: An updated systematic review and meta-analysis. Front Psychiatry. 2023; 14: 1118836. doi: 10.3389/fpsyt.2023.1118836
El-Serag H.B., Sweet S., Winchester C.C. et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014; 63 (6): 871–80. doi: 10.1136/gutjnl-2012-304269
Ghoshal U.C., Sonthalia N., Roy A. et al. Metabolic Syndrome and Gastroesophageal Reflux Disease: Clinical Remission with Treatment, Beyond an Epidemiological Association. J Neurogastroenterol Motil. 2025; 31 (1): 1–2. doi: 10.5056/jnm24175
Gyawali C.P., Yadlapati R., Fass R. et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024; 73 (2): 361–71. doi: 10.1136/gutjnl-2023-330616
Calabrese F., Pasta A., Bodini G. et al. Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms – A multicentre retrospective study. Aliment Pharmacol Ther. 2024; 59 (9): 1134–43. doi: 10.1111/apt.17934
Karimian M., Salamati M., Azami M. The relationship between metabolic syndrome and increased risk of Barrett's esophagus: an updated systematic review and meta-analysis. BMC Gastroenterol. 2020; 20 (1): 138. doi: 10.1186/s12876-020-01267-2
Kim Y., Park J.H., Kim D.H. et al. Impact of Metabolic Health and Its Changes on Erosive Esophagitis Remission: A Cohort Study. J Neurogastroenterol Motil. 2025; 31 (1): 43–52. doi: 10.5056/jnm24058